1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CBX5 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA PANK1 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA ZNF250 CTRPv2 pan-cancer AAC 0.18 4e-08
mRNA KANSL3 CTRPv2 pan-cancer AAC 0.17 4e-08
mRNA MRPL9 CTRPv2 pan-cancer AAC -0.17 5e-08
mRNA CLASRP CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA HNRNPA1L2 CTRPv2 pan-cancer AAC 0.2 5e-08
mRNA ZNF302 CTRPv2 pan-cancer AAC 0.17 5e-08
mRNA ZNF100 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA PBRM1 CTRPv2 pan-cancer AAC 0.19 5e-08
Download CSV